Article | May 4, 2021

Scale-Up: The Next Mountain To Climb In Technology Transfers

Source: Bora Pharmaceuticals

By Lonnie Barish, MBA, VP of Business Development and Marketing, Bora Pharmaceuticals


Turning a promising drug candidate into a successful pharmaceutical product involves scaling-up the processes, developed in the research lab, in order that commercial supply can be achieved. The technical hurdles involved in making this transfer can be daunting.

Also, it is not uncommon for changes to be made in the manufacturing process and/or chemistry of a drug product following approval and the changes can continue throughout its life cycle to improve the product. Depending upon the circumstances, there can be changes to the raw materials, production process, equipment train, manufacturing site and/or batch size which can ultimately affect Critical Quality Attributes (CQAs) of a drug or finished product.

Fortunately, pharmaceutical companies can help themselves by planning for scale-up and commercialization if they are doing these Technology Transfers at the earliest stages of drug development.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online